Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CXSL2400196	注射用DB-1305	DB-1305	Lyophilized	Biological Products(1)	New Drug Application	2024-03-20	Yingen Biopharmaceutical (Suzhou) Co Ltd	view
CXSB2300143	注射用DB-1305	DB-1305	Lyophilized	Biological Products(1)	Supplementary Application	2023-12-12	Yingen Biopharmaceutical (Suzhou) Co Ltd	view
CXSB2300108	注射用DB-1305	DB-1305	Lyophilized	Biological Products(1)	Supplementary Application	2023-10-11	Yingen Biopharmaceutical (Suzhou) Co Ltd	view
CXSB2200085	注射用DB-1305	DB-1305	Lyophilized	Biological Products(1)	Supplementary Application	2022-10-27	Yingen Biopharmaceutical (Suzhou) Co Ltd	view
CXSB2200076	注射用DB-1305	DB-1305	Lyophilized	Biological Products(1)	Supplementary Application	2022-09-24	Yingen Biopharmaceutical (Suzhou) Co Ltd	view
CXSL2200248	注射用DB-1305	DB-1305	Lyophilized	Biological Products(1)	New Drug Application	2022-06-07	Yingen Biopharmaceutical (Suzhou) Co Ltd	view